OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

OraSure Technologies, Inc.NASDAQ: OSUR

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 37.4%

Gross margin was 37.4% in Q1 FY2026, down 3.7 pp from a year earlier. On a trailing-twelve-month basis it was 41.0%, down 1.5 pp year over year. Over 3 fiscal years it widened by 3.6 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
37.4%-3.5 pp QoQ
Last fiscal yearDec 2025
41.9%+0.9 pp YoY
LTMMar 2026
41.0%-1.5 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.7 pp——
1 year+0.9 pp——
3 years+3.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
41.9%
Year-over-year change
+0.9pp

Gross Margin vs competitors

How OSUR compares with its peers on the latest reported figures

  • OSUR's LTM Mar 2026 gross margin of 41.0% is the 7th highest of the 8 companies compared; the peer median is 53.6%.
  • Its year-over-year change of -1.5 pp is the 3rd highest of 7, against a peer median of -8.8 pp.
  • Over three fiscal years its change of +3.6 pp compares with a peer median of -4.8 pp.
OSUR Competitors Peer median
Gross Margin for OSUR and competitors
Company Period LTM level YoY 3-year change
NTHINeonc Technologies Holdings, Inc.FY2025100.0% ——
PROFProfound Medical Corp.LTM Mar 202671.1% +4.4 pp+25.6 pp
PREPrenetics Global LimitedLTM Mar 202658.3% +12.7 pp+25.3 pp
UTMDUtah Medical Products, Inc.LTM Mar 202653.6% -2.1 pp-10.0 pp
NYXHNyxoah S.A.LTM Mar 202648.3% -17.2 pp+0.4 pp
STIMNeuronetics, Inc.LTM Mar 202648.0% -15.6 pp-27.8 pp
OSUROraSure Technologies, Inc.LTM Mar 202641.0% -1.5 pp+3.6 pp
CATXPerspective Therapeutics, Inc.LTM Mar 2026-489.8% -407.5 pp-290.8 pp
NAUTNautilus Biotechnology, Inc.FY2025— ——
TARAProtara Therapeutics, Inc.FY2025— ——
Peer median (excluding OSUR) 53.6%-8.8 pp-4.8 pp

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue233.67M387.48M405.47M185.83M115.02M
Cost of Revenue116.07M239.04M226.05M109.6M66.82M
Gross Profit117.6M148.44M179.42M76.23M48.2M
Gross Margin50.3%38.3%44.2%41.0%41.9%
Research & Development34.17M36.24M33.16M24.42M42.53M
Selling, General & Admin95.08M117.44M92.18M72.41M73.79M
Operating Expenses129.25M153.68M125.34M96.83M116.32M
Depreciation & Amortization11.66M14M19.9M10.87M9.97M
EBITDA2.37M(1.68M)76.16M(6.83M)(56.96M)
EBITDA Margin1.0%-0.4%18.8%-3.7%-49.5%
Operating Income(11.65M)(5.24M)54.08M(20.6M)(68.12M)
Operating Margin-5.0%-1.4%13.3%-11.1%-59.2%
Interest Income00000
Interest Expense00000
Other Income / Expenses2.36M(10.43M)2.18M2.9M1.19M
Income Before Tax(9.29M)(15.68M)56.26M(17.7M)(66.93M)
Pre-Tax Margin-4.0%-4.0%13.9%-9.5%-58.2%
Income Tax Expense13.71M1.46M2.6M1.8M1.8M
Net Income(23M)(17.13M)53.66M(19.5M)(68.73M)
Net Margin-9.8%-4.4%13.2%-10.5%-59.8%
EPS (Basic)(0.32)(0.25)0.73(0.26)(0.94)
EPS (Diluted)(0.32)(0.25)0.72(0.26)(0.94)
Weighted Avg Shares71.98M72.51M73.35M74.43M73.49M
Weighted Avg Shares (Diluted)71.98M72.51M74.39M74.43M73.49M

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.